Supplementary Table 1.docx (21.76 kB)
Supplementary Table 1: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study
dataset
posted on 2021-11-18, 09:13 authored by Shin-ichi Konno, Takuya Nikaido, John D Markman, Makoto Ohta, Toshiya Machida, Naoki Isogawa, Hiroki Yoshimatsu, Lars Viktrup, Mark T Brown, Christine R West, Kenneth M Verburg|
Supplementary Table 1. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized, Celecoxib-Controlled, Japanese, Phase 3, Safety Study Imputation of missing LBPI and RMDQ data |
